During HHT Awareness Month, UCSF is highlighting the work of Steven Hetts, MD, chief of interventional neuroradiology and principal investigator of the AVIATOR Project, a study designed to simplify and improve imaging for patients with HHT.
Torianna Lomax Truong, MS, makes a trip to Washington DC to raise awareness about HHT. Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder characterized by abnormal blood vessel growth.
June is HHT Awareness Month, a time to raise awareness of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder affecting the blood vessels. A team of experts from UCSF Radiology and Pediatrics wrote a review published in Radiology on the role of radiologists in the diagnosis and management of HHT.
Submitted by econnor on September 23, 2016 - 7:51am
As a leading practitioner and medical innovator specializing in the management of vascular abnormalities, Dr. Steven Hetts brings an extraordinary skill set together to bridge clinical treatment and leading-edge technology development for managing hereditary hemorrhagic telangiectasia (HHT.)
As Northern California’s only facility that specializes in the diagnosis and treatment of hereditary hemorrhagic telangiectasia (HHT), UCSF has been named a Center of Excellence by the HHT Foundation International, Inc!
